In one paragraphArticle in Physiological measurement, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
6 authors.
G Barron Del SolarCalifornia Medical Innovations Institute, San Diego, CA, United States of America.ORCID 0009-0001-3639-3606 F J MoawadScripps Clinic, Division of Gastroenterology, La Jolla, CA, United States of America.
J E PandolfinoNorthwestern University, Department of Gastroenterology and Hepatology, Feinberg School of Medicine, Chicago, IL, United States of America.ORCID 0000-0002-4993-9559 Funding
Fecobionics device for mapping colonic and anorectal neuromuscular functionOT2OD025308 · OD · CALIFORNIA MEDICAL INNOVATIONS INSTITUTE · PI GREGERSEN, HANS, KASSAB, GHASSAN S · 2017 to 2020
$3.6MPathophysiology, diagnosis and biofeedback therapy in fecal incontinence using fecobionicsR01DK131488 · NIDDK · CALIFORNIA MEDICAL INNOVATIONS INSTITUTE · PI Hans Gregersen, Satish SC Rao · 2022 to 2026
$3.2MNeurophysiological mechanism in sacral neuromodulation in patients suffering from fecal incontinenceOT2OD028203 · OD · CALIFORNIA MEDICAL INNOVATIONS INSTITUTE · PI GREGERSEN, HANS · 2019 to 2021
$3.1MDefecation mechanisms and subtyping of constipation patients with FecobionicsR01DK125657 · NIDDK · CALIFORNIA MEDICAL INNOVATIONS INSTITUTE · PI GREGERSEN, HANS · 2021 to 2025
$3.0MBiomechatronics Device for Diagnosis/Therapy of Anorectal DisordersR44DK129097 · NIDDK · 3DT HOLDINGS, LLC · PI COMBS, WILLIAM, GREGERSEN, HANS · 2021 to 2023
$2.1MFecobionics monitoring and prediction of biofeedback therapy outcome in patients with obstructed defecation.R01DK134689 · NIDDK · CALIFORNIA MEDICAL INNOVATIONS INSTITUTE · PI GREGERSEN, HANS, KASSAB, GHASSAN S · 2023 to 2025
$1.1MNIDDK NIH HHS R01 DK125657NIDDK NIH HHS R01 DK131488NIDDK NIH HHS R01 DK134689NIDDK NIH HHS R44 DK129097NIH HHS OT2 OD025308NIH HHS OT2 OD028203
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
BionicsDeglutitionEsophagusGastrointestinal TransitAdultFeasibility StudiesFemaleHumansMalePressureaxial pressurebionicesophagusmotilityswallowingtransit
Identifiers
PMID41839159
PMCPMC13197135
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390